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’The fee reductions have been made possible by the
continuous and successful efforts of management and
staff to raise the quality of service and reduce unit costs
since the Patent Office relocated to Newport, South
Wales, in 1991’.
Details of the fee reductions are available on the Patent
Office Web site at www.patent.gov.uk/snews/notices/red-
fee.html. Copies of the statutory instruments are avail-
able fi’om the Stationery Office Bookshops and from the
Patent Office. They are The Trade Marks (Fees) Rules 1998
(SI 1998 No 1776), 1.10; The Registered Designs (Fees)
Rules 1998 (SI 1998 No 1777), 1.10 and The Patents
(Fees) Rules 1998 (SI 1998 No 1778), 1.95).
For information, contact Brian Caswell, The Patent Offce,
+44 (0)1633 814729 or Michael Binns, Prowse & Co,
+ 44 (0)1372 363386.
21st century requirements to monitor our envir-
onment prompts action by The Royal Society of
Chemistry
Modern instrumentation has allowed us to push back the
fi’ontiers of detection such that we are able to determine
incredibly small anaounts of natural and anthropogenic
pollutants and contaminants in our environment,
whether they are in our homes, workplaces, cities, the
countryside or the oceans. The fact that we can detect
these pollutants in minuscule amounts does not necess-
arily mean that the levels present in the environment are
harmful to our health or well being, but it does drive
world-wide legislation on these substances. Theretbre,
there is a requirement to monitor, ascertain the sources,
prevent the release, develop better detection methods and
make properly assessed scientific judgements on the
toxicity, exposure and risk assessment of the pollutants
to which we are exposed in our daily lives.
The Royal Society of Chemistry has recognized the
importance of these 21st century requirements, and that
it is essential to promote and disseminate the knowledge
of newly developed technologies for monitoring our vari-
ous environments. Therefore, it is launching the Journal of
Environmental Monitoring (JEM) which is dedicated to
assessing exposure and health risks through the latest
developments in measurement science. The journal, with
the first issue due to be published in February 1999 and
then bi-monthly thereafter, is unique in that it aims to
publish all the relevant information on this subject area
in one source.
This journal is intended for environmental and health
professionals in industry, and officials ii’om governmental
and regulatory agencies as well as research scientists
interested in the environment.
"I think the journal will be of interest to all analytical
scientists involved with environmental monitoring issues.
Currently at NIOSH, environmental monitoring is one of
the key components of the National Occupational Re-
search Agenda (NORA)". Dr E. R. Kennedy, NIOSH,
Cincinnati, USA.
"Environmental contaminants are becoming the No.
public concern". Mr J. V. Dutton, Consultant, UK.
"The launching of a journal dedicated to environmental
monitoring with some emphasis on legislative issues is an
excellent idea". Dr. Philippe Quevauviller, European
Commission, DGXII SM&T Programme, Belgium.
The Royal Society of Chemistry (RSC) is a learned
society with a worldwide membership of 46000. it has
as its main objectives the advancement of the science of
chemistry and its applications, and the maintenance of
high standards of competence and integrity among
practising chemists. The RSC markets a comprehensive
range of high quality information products and services.
For further details contact: Harpal Minhas, The Royal
Society of Chemistry, Thomas Graham House, Science
Park, Milton Road, Cambridge CN4 4WF, UK. Tel"
+ 44 (0) 1223 432292; Fax: + 44 (0) 1223 420247; e-mail:
jem@rsc.org; URL: www.rsc.org/jem
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Micromass host international seminar on the
enabling role of MS
Micromass, the mass spectrometry people, hosted MS in
Proteomics & Drug Discovery: An International Seminar on the
Enabling Role ofMS. The seminar, which was open to the
public and incorporated Micromass’ 1998 organic MS
users’ meeting, the first event of its kind to be organized
by the company since its re-formation in 1996.
The seminar saw a move from central Manchester, the
traditional home of the Micromass user meeting, to
Shrigley Hall in Cheshire. From 18th to 20th October
1998, this impressive 19th century country mansion
housed an international panel of invited speakers and
Micromass users, presenting an insight into emerging
MS-based strategies in proteomics and contemporary
drug discovery]development. Speakers included Roland
Annan (SmithKline Beecham, PA, USA), Walter Black-
stock (Glaxo Wellcome, UK), Daryl Pappin (Imperial
Cancer Research Foundation, UK) and Jeffrey Kiplin-
get (Pfizer, Groton, CT, USA).
Originally planned as a ’stand-alone’ meeting to be
hosted, earlier in 1998, by Glaxo-Wellcome, the proteo-
mics sessions were, through unexpectedly popular de-
mand, rescheduled at this larger venue. Protein
identification using MS and bio-informatics is becoming
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routine in the quest for new targets, with known proteins
being rapidly identified via comparison ofMS data with
genome, EST or protein databases. Unknown proteins
require the use of partial sequencing by MS-MS for the
construction of oligonucleotide probes or primers. Ad-
ditionally, de novo sequencing of peptide fragments is
being automated. Initially focusing on current achieve-
ments in protein characterization using Q-TofTM MS-
MS systems, the intention of this seminar was to present
an assessment of what was currently achievable, the
limitations and what problems remained to be solved.
Moving onto the pharmaceutical industry, the seminar
investigated one of the most important changes taking
place within it, i.e. the rapid expansion of discovery
operations. MS contributes to this process in several
ways, including the provision of structural support for
synthetic chemistry, autopurification prior to screening
and LC-MS in lead optimization. LC-MS(MS) is now
being used to evaluate drug candidate metabolism and
pharmacokinetics at both the early and late development
stages. Discovery teams are increasingly being requested
to focus on the survival of candidates to and beyond first
testing in human subjects, touching off a strong push to
move testing traditionally done in a develol)ment setting
into the high throughput early discovery environment.
LC-TOF MS mass analysers (LCT/Q-Tof) were high-
lighted in view of their significant potential to leverage
throughput and data quality in these challenging appli-
cations.
For further information, contact Dawn Eaton, Micromass UK
Limited, 3 Tudor Road, Altrincham, Cheshire WA145RZ, UK.
Tel: +44(0)1612829666". Fax: +44(0)1612824400. E-
mail: dawn.eaton@micromass.co.uk
ISLAR ’98
Cooler temperatures and changing leaves not only signal
the annual arrival of autumn, but also the return of the
International Symposium on Laboratory Automation
and Robotics (ISLAR). On 18-21 October 1998, the
world’s leading scientists and managers convened in
Boston, MA, for an innovative experience at the 16th
annual ISLAR symposium.
With over 130 podium and poster presentations, ISLAR
’98 is the world’s largest forum to learn about the latest
developments in automation and robotics. Its unique
format features both management and technical presen-
tations, making it the most important industry-related
conference of the year. World-renowned scientists and
managers in the biotechnology, pharmaceutical, chemi-
cal and consumer products industries shared their insight
on the importance of using the latest technology and
strategies to increase productivity and reduce time to
market.
The three-day program included a series of discussion
groups, workshops, short courses and presentations devel-
oped for managers to exchange ideas and experiences. A
new feature at ISLAR ’98 was an Ultra High Through-
put Screening session where scientists and managers from
around the world discussed industry challenges, the new
era of HTS, and how automation was being used as a
critical component in the advancement of high-through-
put screening.
Attendees and presenters at ISLAR ’97 participated in a
survey which resulted in several new sessions debuting at
ISLAR ’98, including the following.
Assay miniaturization technologies
The role of bioinformatics in pharmaceutical research
The impact of automation on secondary screening
Managing laboratory automation in pharmaceutical
analysis
Methods transfer and validation
Inhalation applications
To help members of the media maximize their experi-
ences at the symposium, ISLAR ’98 featured a series of
editorial roundtables focusing on drug discovery, analy-
tical research and development, and quality control/
quality assurance. The roundtable panels featured key-
note speakers and symposium presenters to help facilitate
discussions.
For more detailed information and abstracts, access the ISLAR
web site at http://www.islar.com. The next issue 0fJournal of
Automated Methods & Management in Chemistry will
feature abstractsfrom ISLAR ’98
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